A 50% month-on-month funding drop in April sounds alarming. In context, it's more interesting than that.
Eight deals. Approximately $119m raised. A roughly 50% drop from March's already low $237m, and a long way from February's $1bn-plus peak.
For the first time this year, not a single deal exceeded $100m. That's not a blip: it sits against a backdrop where $100m+ deals dropped significantly by 85% in H1 2025 versus the previous period. The era of nine-figure InsurTech rounds being routine appears, for now, to be behind us.
But here's what is more instructive than the headline decline: where the money is going.
Half of all April deals were in AI and automation: underwriting, claims, back-office infrastructure. Embedded insurance and distribution models made up most of the rest. Investors aren't stepping back from InsurTech. They're becoming far more deliberate about the type of InsurTech they'll back.
The largest round of the month went to Counterpart*, raising $50m for its AI-driven underwriting platform. Specialist. Data-led. A clear thesis. That pattern is consistent across the active deals.
US companies continue to dominate, accounting for five of the eight transactions - in line with their 51% share of all global InsurTech deals in Q1 2026.
For those of us placing executive and go-to-market talent into this space, the funding environment tells a nuanced story. Capital is tighter, but it's not absent: it's concentrating around businesses with genuine IP, clear distribution logic, and the operational leadership to scale efficiently.
In a market like this, the calibre of the team around the founding vision matters more than ever.
What are you seeing on the ground in terms of hiring appetite right now? I'd be keen to hear perspectives from both investors and operators. 👇
(* to find out more about Counterpart's raise - look out for a future episode of The Leadership In Insurance Podcast featuring CEO Tanner Hackett in conversation with FinPro. founder and podcast host, Alex Bond)
📊 Source: InsurTech Analyst, May 2026
